The potential of cerium oxide nanoparticles (nanoceria) for neurodegenerative disease therapy

Nanomedicine

Volumn 9, Issue 10, 2014, Pages 1437-1440

  Estevez, Ana Y ^a   Erlichman, Joseph S ^a  

^a ST LAWRENCE UNIVERSITY   (United States)

Author keywords

cerium oxide; nanoceria; neurodegenerative disease; oxidative stress

Indexed keywords

ANTIOXIDANT; CATALASE; CERIUM OXIDE; EDETIC ACID; GOLD NANOPARTICLE; NANOMATERIAL; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; CERIC OXIDE; CERIUM; METAL NANOPARTICLE;

AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANT ACTIVITY; BRAIN ISCHEMIA; DEGENERATIVE DISEASE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GENE EXPRESSION; HIPPOCAMPUS; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; REVIEW; SYNTHESIS; ANIMAL; BIOLOGICAL MODEL; BRAIN; DRUG EFFECTS; FEASIBILITY STUDY; HUMAN; METABOLISM; NEURODEGENERATIVE DISEASES;

ANIMALS; ANTIOXIDANTS; BRAIN; CERIUM; FEASIBILITY STUDIES; HUMANS; METAL NANOPARTICLES; MODELS, NEUROLOGICAL; NEURODEGENERATIVE DISEASES; REACTIVE OXYGEN SPECIES;

EID: 84907454597     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.14.87     Document Type: Review

References (20)

1. Estevez AY, Erlichman JS. Cerium oxide nanoparticles for the treatment of neurological oxidative stress diseases. In: Oxidative Stress: Diagnostics, Prevention and Therapy (Volume 1083). Andreescu ES, Hempel M (Eds). American Chemical Society, Washington, DC, USA, 255-288 (2011).
2. Das S, Dowding JM, Klump KE, McGinnis JF, Self W, Seal S. Cerium oxide nanoparticles: applications and prospects in nanomedicine. Nanomed. (Lond.) 8(9), 1483-1508 (2013).
3. Estevez AY, Pritchard S, Harper K, et al. Neuroprotective mechanisms of cerium oxide nanoparticles in a mouse hippocampal brain slice model of ischemia. Free Radic. Biol. Med. 51(6), 1155-1163 (2011).
4. Heckman KL, DeCoteau W, Estevez A, et al. Custom cerium oxide nanoparticles protect against a free radical mediated autoimmune degenerative disease in the Brain. ACS Nano 7(12), 10582-10596 (2013).
5. Hirst SM, Karakoti AS, Tyler RD, Sriranganathan N, Seal S, Reilly CM. Anti-inflammatory properties of cerium oxide nanoparticles. Small 5(24), 2848-2856 (2009).
6. Pirmohamed T, Dowding JM, Singh S, et al. Nanoceria exhibit redox state-dependent catalase mimetic activity. Chem. Commun. (Camb.) 46(16), 2736-2738 (2010).
7. Korsvik C, Patil S, Seal S, Self WT. Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chem. Commun. (Camb.) 10(10), 1056-1058 (2007).
8. Ganesana M, Erlichman JS, Andreescu S. Real-time monitoring of superoxide accumulation and antioxidant activity in a brain slice model using an electrochemical cytochrome c biosensor. Free Radic. Biol. Med. 53(12), 2240-2249 (2012).
9. Kang KW, Lee SJ, Kim SG. Molecular mechanism of nrf2 activation by oxidative stress. Antioxid. Redox Signal. 7(11-12), 1664-1673 (2005).
10. Neymotin A, Calingasan NY, Wille E, et al. Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis. Free Radic. Biol. Med. 51(1), 88-96 (2011).
11. Hardas SS, Sultana R, Warrier G, et al. Rat hippocampal responses up to 90 days after a single nanoceria dose extends a hierarchical oxidative stress model for nanoparticle toxicity. Nanotoxicology 1-12 (2013).
12. Kumari M, Singh SP, Chinde S, Rahman MF, Mahboob M, Grover P. Toxicity study of cerium oxide nanoparticles in human neuroblastoma cells. Int. J. Toxicol. 33(2), 86-97 (2014).
13. Dowding JM, Das S, Kumar A, et al. Cellular interaction and toxicity depend on physicochemical properties and surface modification of redox-active nanomaterials. ACS Nano 7(6), 4855-4868 (2013).
14. Deng ZJ, Liang M, Monteiro M, Toth I, Minchin RF. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat. Nanotechnol. 6(1), 39-44 (2011).
15. Deng ZJ, Mortimer G, Schiller T, Musumeci A, Martin D, Minchin RF. Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology 20(45), 455101 (2009).
16. Levy R, Thanh NTK, Doty RC, et al. Rational and combinatorial design of peptide capping ligands for gold nanoparticles. J. Am. Chem. Soc. 126(32), 10076-10084 (2004).
17. Walczyk D, Bombelli FB, Monopoli MP, Lynch I, Dawson KA. What the cell "sees" in bionanoscience. J. Am. Chem. Soc. 132(16), 5761-5768 (2010).
18. Walkey CD, Olsen JB, Song F, et al. Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. ACS Nano 8(3), 2439-2455 (2014).
19. Asati A, Santra S, Kaittanis C, Perez JM. Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles. ACS Nano 4(9), 5321-5331 (2010).
20. Hardas SS, Sultana R, Warrier G, et al. Rat brain pro-oxidant effects of peripherally administered 5 nm ceria 30 days after exposure. Neurotoxicology 33(5), 1147-1155 (2012).